CV, Kidney and Metabolic Health Research Section

📢New in Heart Failure Reviews: #MIGHTyHeartTrial results. Mobile Integrated Health did not reduce 30-day readmission in HF patients vs. usual hospital transition care overall but may benefit younger and female patients. Ed: @AndrewPAmbrosy @KPDOR pubmed.ncbi.nlm.nih.gov/40853421/

New study alert! Earlier initiation of #dapagliflozin in #HFpEF/#HFmrEF post-HF hospitalization yields greatest value—lowest ICER when started ≤1 mo post-discharge. @ankeetbhatt @KPDOR. J Cardiac Failure (2025) pubmed.ncbi.nlm.nih.gov/40759248/ #HeartFailure #DELIVERTrial

New study in JACC - Among >28K pts with HFrEF, >30% had improved LVEF (HFimpEF) at 12 months. Despite better outcomes with HFimpEF, modest GDMT withdrawal was associated with ↑ clinical risk. Co-authors: @asgmd1 , @AndrewPAmbrosy , @ankeetbhatt & team.

The AHA's National Integrated #ASCVD Initiative shows how structured implementation can improve lipid management at scale. @KPDOR @ankeetbhatt +24.7% ↑ in stroke lipid referrals +2.8% ↑ in LDL-C monitoring Heart & Stroke Helper app: 3,600+ downloads doi.org/10.1161/CIRCOU…

📢 New Research from @CKMResearch @KPDOR @ankeetbhatt "Cardiovascular-Kidney-Metabolic Syndrome: A Paradigm for Value-Based Care" proposes an integrated model to tackle urgent & costly health crisis in the U.S. 🔗 Read: onlinejcfi.org/article/S3050-… #ValueBasedCare #CKM #HealthEquity

News from @CKM_Research @KPDOR @davidouyang and colleagues awarded a $5M grant from @American_Heart to study how AI can enhance the value of routine heart ultrasounds to detect kidney and liver conditions for improving CKM health. #AIinHealthcare #CardioAI #HeartHealth